ASTA Corporation (KOSDAQ:246720)

Market Cap	83.21B
Revenue (ttm)	3.39B
Net Income (ttm)	-2.88B
Shares Out	14.32M
EPS (ttm)	-223.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,924
Average Volume	70,867
Open	5,770.00
Previous Close	5,810.00
Day's Range	5,600.00 - 5,790.00
52-Week Range	3,810.00 - 6,860.00
Beta	1.60
RSI	53.61
Earnings Date	Aug 14, 2025

About MorphoSys AG

ASTA Corporation engages in the development of diagnosis solutions in South Korea. The company offers microorganism identification systems, such as MicroIDSys and MicroIDSys Elite, which is used for applications in the areas of rapid diagnosis of infectious diseases, food hygiene management, agriculture and stockbreeding quarantines, and prevention of bio-terrorism. It also iprovides IDSys LT/RT, a MALDI-TOF mass spectrometry solution; NosIDSys, an economical diagnostic system used for diagnosis and prevention of rare incurable diseases, such a...

• Industry: Laboratory Analytical Instruments
• Founded: 2006
• Employees: 29
• Stock Exchange: KOSDAQ
• Ticker Symbol: 246720

Financial Performance

In 2022, ASTA Corporation's revenue was 3.35 billion, an increase of 30.48% compared to the previous year's 2.56 billion. Losses were -2.80 billion, -20.74% less than in 2021.